Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 3/20 | 0.38 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.37 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.36 |
| ▸ | CDK2 | P24941 | 2/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12174907 | 0.82 | HCAR2 (0.47) | HCAR2DAOALPLCCNA2CDK2 | |
| SCHEMBL877436 | 0.82 | HCAR2 (0.52) | HCAR2DAOALPLCCNA2CDK2 | |
| Hydrochloric Acid SCHEMBL1371875 | 0.81 | HCAR2 (0.50) | HCAR2DAOALPLCCNA2CDK2 | |
| SCHEMBL3587984 | 0.78 | KDM4E (0.48) | HCAR2DAOALPLCCNA2CDK2 | |
| SCHEMBL12158535 | 0.78 | HCAR2 (0.43) | HCAR2DAOALPLCCNA2CDK2 | |
| SCHEMBL8720083 | 0.77 | SMN1; SMN2 (0.51) | HCAR2DAOPOLBKMT2ACYP2C9 | |
| SCHEMBL31498925 | 0.74 | HCAR2 (0.43) | HCAR2DAOHTTCCNA2CDK2 | |
| SCHEMBL12985517 | 0.73 | HTT (0.48) | HCAR2DAOHTTALPLCSNK2A2 | |
| SCHEMBL19334092 | 0.73 | HCAR2 (0.39) | HCAR2DAOALPLPOLBKMT2A | |
| SCHEMBL3465530 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4316492-B1 | COMBINATION OF A MULTIKINASE INHIBITOR WITH A PD-1/PD-L1 ANTIBODY AND USES THEREOF | TRANSTHERA SCIENCES NANJING INC (CN) | 2025-12-03 | — | — | EP | disclosed |
| US-11718620-B2 | Method for treating a cancer mediated by abnormality of multi-kinases | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2023-08-08 | — | — | US | disclosed |
| CN-115698008-A | Pyrazolo [1,5-a ] pyrimidine derivatives having multimodal activity against pain | 埃斯特韦制药股份公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-2627653-A1 | 3 -AMINO- PYRAZOLE DERIVATIVES USEFUL AGAINST TUBERCULOSIS | Glaxo Group Limited (GB) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012049161-A1 | 3 -AMINO- PYRAZOLE DERIVATIVES USEFUL AGAINST TUBERCULOSIS | GLAXO GROUP LIMITED (GB) | 2012-04-19 | — | — | WO | disclosed |
| WO-2005092841-A1 | COMPOUNDS HAVING BETA-AGONIST ACTIVITY | PFIZER LIMITED (GB) | 2005-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718620-B2 | Method for treating a cancer mediated by abnormality of multi-kinases | MAP3K1, MAP3K5, MAP3K2 | HCAR2 3759/4885DAO 2261/4885HTT 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.